Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3033 |
|
| Actual shortage: | 243 (8%) | |
| Anticipated shortage: | 15 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2766 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
29 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-OLMESARTAN | 20MG | TABLET | Actual shortage | 2024-01-19 | 2024-05-02 | 216711 |
| APO-PREGABALIN | 25MG | CAPSULE | Actual shortage | 2024-01-19 | 2024-05-08 | 216732 |
| APO-PREGABALIN | 75MG | CAPSULE | Actual shortage | 2024-01-19 | 2024-05-08 | 216741 |
| APO-MIDODRINE | 5MG | TABLET | Actual shortage | 2024-01-26 | 2024-04-05 | 217472 |
| APO-GLICLAZIDE MR | 60MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-01-26 | 2024-03-27 | 217481 |
| APO-BUSPIRONE | 10MG | TABLET | Actual shortage | 2024-01-26 | 2024-02-02 | 217484 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Actual shortage | 2024-02-02 | 2024-03-27 | 218379 |
| APO-OXCARBAZEPINE | 150MG | TABLET | Actual shortage | 2024-02-09 | 2024-04-12 | 219159 |
| APO-MIDODRINE | 2.5MG | TABLET | Actual shortage | 2024-02-09 | 2024-03-22 | 219162 |
| APO-AMLODIPINE-ATORVASTATIN | 80MG 10MG | TABLET | Actual shortage | 2024-02-16 | 2024-05-03 | 219843 |
| APO-BACLOFEN | 10MG | TABLET | Actual shortage | 2024-03-08 | 2024-04-05 | 221696 |
| APO-METHYLPHENIDATE | 5MG | TABLET | Actual shortage | 2024-03-08 | 2024-05-03 | 221723 |
| APO-RIVASTIGMINE | 1.5MG | CAPSULE | Actual shortage | 2024-03-08 | 2024-03-22 | 221729 |
| APO-BACLOFEN | 20MG | TABLET | Actual shortage | 2024-03-15 | 2024-05-03 | 222455 |
| APO-NAPROXEN | 500MG | TABLET | Actual shortage | 2024-03-15 | 2024-04-05 | 222478 |
| APO-OLOPATADINE | 0.2% | SOLUTION | Actual shortage | 2024-03-27 | 2024-03-27 | 223564 |
| APO-GLICLAZIDE | 80MG | TABLET | Actual shortage | 2024-04-05 | 2024-04-26 | 224583 |
| APO-WARFARIN | 1MG | TABLET | Actual shortage | 2024-04-05 | 2024-04-26 | 224589 |
| APO-FLUVOXAMINE | 100MG | TABLET | Actual shortage | 2024-04-05 | 2024-05-03 | 224592 |
| APO-OXCARBAZEPINE | 300MG | TABLET | Actual shortage | 2024-04-05 | 2024-04-12 | 224598 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROMORPHONE CR | 30MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110971 |
| APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |
| APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |
| APO-AMOXI SUGAR FREE | 250MG | POWDER FOR SUSPENSION | Discontinued | 2020-06-22 | 2020-06-22 | 118526 |
| APO-QUETIAPINE | 25MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 119950 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-QUETIAPINE | 25MG | TABLET | Discontinued | 2021-06-25 | 2021-06-25 | 141546 |
| APO-PINDOL TAB 5MG | 5MG | TABLET | Discontinued | 2022-02-09 | 2022-02-10 | 154568 |
| APO-PINDOL TAB 10MG | 10MG | TABLET | Discontinued | 2022-02-09 | 2022-02-10 | 154571 |
| APO-PINDOL TAB 15MG | 15MG | TABLET | Discontinued | 2022-02-09 | 2022-12-09 | 154574 |
| MELPHALAN FOR INJECTION | 10ML 50MG | POWDER FOR SOLUTION KIT SOLUTION | Discontinued | 2022-03-23 | 2022-03-23 | 157136 |
| APO-BICALUTAMIDE | 50MG | TABLET | Discontinued | 2022-03-25 | 2022-05-13 | 157376 |
| APO-CLOBETASOL SPRAY | 0.05% | SPRAY | Discontinued | 2022-09-06 | 2022-09-06 | 168648 |
| APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE | 300MG 150MG 300MG | TABLET | Discontinued | 2022-12-12 | 2022-12-12 | 177953 |
| APO-VALPROIC ACID ORAL SOLUTION | 250MG | SOLUTION | Discontinued | 2023-09-26 | 2023-11-02 | 205310 |
| APO-CARVEDILOL | 25MG | TABLET | Discontinued | 2024-01-26 | 2024-01-27 | 217504 |